Medical Research Council Human Immunology Unit, Nuffield Department of Medicine, Medical Research Council Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
Nat Immunol. 2010 Nov;11(11):1039-46. doi: 10.1038/ni.1942. Epub 2010 Oct 3.
Neutrophils are the main effector cells during inflammation, but they can also control excessive inflammatory responses by secreting anti-inflammatory cytokines. However, the mechanisms that modulate their plasticity remain unclear. We now show that systemic serum amyloid A 1 (SAA-1) controls the plasticity of neutrophil differentiation. SAA-1 not only induced anti-inflammatory interleukin 10 (IL-10)-secreting neutrophils but also promoted the interaction of invariant natural killer T cells (iNKT cells) with those neutrophils, a process that limited their suppressive activity by diminishing the production of IL-10 and enhancing the production of IL-12. Because SAA-1-producing melanomas promoted differentiation of IL-10-secreting neutrophils, harnessing iNKT cells could be useful therapeutically by decreasing the frequency of immunosuppressive neutrophils and restoring tumor-specific immune responses.
中性粒细胞是炎症过程中的主要效应细胞,但它们也可以通过分泌抗炎细胞因子来控制过度的炎症反应。然而,调节其可塑性的机制尚不清楚。我们现在表明,系统性血清淀粉样蛋白 A1(SAA-1)控制中性粒细胞分化的可塑性。SAA-1 不仅诱导抗炎白细胞介素 10(IL-10)分泌的中性粒细胞,而且促进不变自然杀伤 T 细胞(iNKT 细胞)与这些中性粒细胞的相互作用,这一过程通过减少 IL-10 的产生和增强 IL-12 的产生来限制其抑制活性。由于产生 SAA-1 的黑色素瘤促进了 IL-10 分泌的中性粒细胞的分化,因此通过减少免疫抑制性中性粒细胞的频率并恢复肿瘤特异性免疫反应,利用 iNKT 细胞可能具有治疗价值。